IMARC Group's report "PET-CT Scanner Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032", The global PET-CT scanner device market size reached USD 2.2 billion in 2023. Looking ahead, IMARC Group forecasts that it will reach US$ 3.1 Billion by 2032, exhibiting a growth rate (CAGR) of 3.62% during 2024-2032.
Get a Mr./Ms. pull PDF of this report: https://www.imarcgroup.com/pet-ct-scanner-device-market/requestsample
Global PET-CT Scanner Equipment Market Trends
The growing investments in healthcare infrastructure, particularly in emerging markets, are boosting the adoption of PET-CT scanners. Governments and private entities are increasing their healthcare budgets, leading to the expansion of diagnostic imaging facilities. There is a growing emphasis on early diagnosis and personalized medicine, where PET-CT scanners play a critical role. Early detection of diseases through advanced imaging techniques is becoming a standard practice in clinical settings. The establishment of diagnostic imaging centers and hospitals equipped with advanced PET-CT technology is rising. This expansion is driven by the need for better diagnostic services and the growing demand for accurate and timely diagnostics.
Factors influencing the growth of the PET-CT scanner devices industry:
- Advancements in Imaging Technology:
Ongoing advancements in PET-CT imaging technology result in improved image quality, resolution, and clarity. This enables healthcare providers to obtain more accurate and detailed images of anatomical structures and metabolic processes, leading to better diagnostic accuracy and confidence in clinical decision-making. Moreover, innovations in PET-CT scanners are leading to faster scan times, allowing healthcare facilities to increase patient throughput and efficiency. Shorter scan times also enhance patient comfort and satisfaction while reducing the overall cost and time burden associated with imaging procedures.
- Increasing Incidence of Cancer:
PET-CT scanners are highly effective in detecting cancer at an early stage, even before symptoms manifest. This early detection enables prompt initiation of treatment, leading to better patient outcomes and survival rates. PET-CT imaging also provides detailed information about the extent and spread of cancer within the body, facilitating accurate staging of the disease. This information is crucial for developing personalized treatment plans tailored as per the specific condition of patients.
- Rising Demand for Personalized Medicine:
PET-CT scanners play a crucial role in personalized medicine by providing detailed information about the molecular and metabolic characteristics of tumors. This enables healthcare providers to accurately diagnose cancer subtypes and assess the response of patients to specific treatments, facilitating personalized treatment planning tailored as per the unique biological profile of each patient. In addition, PET-CT imaging is used to monitor the response of patients to various cancer therapies, including chemotherapy, radiation therapy, and targeted therapies. By detecting metabolic changes in tumors over time, PET-CT scans help healthcare providers evaluate treatment efficacy, identify early signs of treatment resistance, and make informed decisions regarding treatment adjustments or modifications.
Leading companies operating in the global PET-CT Scanner Equipment industry:
- Bruker Corporation
- Canon Medical Systems USA, Inc.
- General Electric Company
- Hitachi, Ltd.
- Koninklijke Philips N.V.
- Mediso Inc.
- New Soft Inc.
- Positron Corporation
- Shimadzu Corporation
- Siemens Healthcare GmbH (Siemens AG)
- Sophie Biosciences K.K.
- United Imaging Healthcare, Inc.
- Yangzhou Kindsway Biotechnology Co., Ltd.
PET-CT Scanner Devices Market Report Segmentation:
By Type:
- Stationary scanner
- Portable Scanners/Mobile Scanners
Stationary scanners account for the largest segment due to their high image quality, reliability, and suitability for a wide range of clinical applications.
By number of slices:
- Low-slice scanner (<64-slice)
- Medium Slice Scanner (64 Slices)
- High-Slice Scanner (> 64-slice)
Medium-slice scanners (64 slices) account for the majority of the market share due to their balance between image resolution and cost-effectiveness, making them a popular choice among healthcare professionals.
By Isotope and Detector Type:
- Flurodeoxyglucose (FDG)
- 62Cu ATSM
- 18 F Sodium Fluoride
- FMISO
- gallium
- thallium
- others
Flurodeoxyglucose (FDG) shows a distinct advantage in the market due to its widespread availability, well-established efficacy in cancer imaging, and reimbursement support.
By Service Provider:
- hospital
- Diagnostic Centers
- Research Institutes
Hospitals account for the largest market share by driving comprehensive diagnostic and treatment services, including PET-CT imaging, to a wide patient population.
By Application:
- oncology
- neurology
- cardiology
- others
Oncology dominates the market, which can be attributed to the utilization of PET-CT images in cancer diagnosis, staging, treatment planning, and response assessment.
Regional Insights:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others)
- Latin America (Brazil, Mexico, and others)
- Middle East & Africa
Asia-Pacific enjoys a leading position in the PET-CT scanner devices market owing to the increasing investments in healthcare infrastructure, rising prevalence of cancer, and increasing adoption of advanced medical imaging technologies.
Note: If you need specific information that is not currently included in the scope of the report, it will be provided as part of the customization.
About us:
IMARC Group is a leading market research firm that provides management strategy and market research worldwide. We partner with clients across all sectors and geographies to identify the most valuable opportunities, address the challenges that matter most, and transform their businesses.
IMARC's information products include key market, scientific, economic, and technological developments for business leaders in pharmaceutical, industrial, and high-tech companies. Market forecasting and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology, and new processing methods are at the top of our expertise.
Our services include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team of experienced researchers and analysts from a variety of industries is dedicated to providing high-quality data and insights to everything from small businesses to Fortune 1000 companies.
Contact
IMARC Group
134 N 4th St. Brooklyn, NY 11249 United States
E-mail sales@imarcgroup.com
Phone: (D) +91 120 433 0800
USA: +1-631-791-1145 | UK: +44-753-713-2163
